Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OTLK
Stock Latest News
The Fly
Outlook enters distribution agreement for sale of Lytenava in Switzerland
4d ago
OTLK
Premium
Company Announcements
Outlook Therapeutics Faces Nasdaq Minimum Bid Price Noncompliance
4d ago
8K
OTLK
Premium
Ratings
Neutral Outlook Maintained Amid Slower Lytenava Ramp and Heightened U.S. Regulatory and Market Risks for ONS-5010
5d ago
OTLK
Premium
The Fly
Outlook Therapeutics reports adjusted Q1 EPS (22c), consensus (17c)
6d ago
OTLK
Premium
Company Announcements
Outlook Therapeutics Seeks FDA Meeting on ONS-5010 BLA
11d ago
8K
OTLK
Premium
The Fly
Outlook Therapeutics sumbits Type A meeting request to FDA
12d ago
OTLK
Premium
Pre-Earnings
OTLK Earnings this Week: How Will it Perform?
12d ago
OTLK
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
EC
KDK
Premium
The Fly
Outlook Therapeutics appoints Laura Cantrell as VP, corporate strategy
2M ago
OTLK
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
NFE
USO
Premium
Market News
The Narrowing Pathway for Biotech Securities Fraud Claims: Lessons from Outlook Therapeutics
2M ago
OTLK
Premium
The Fly
Outlook Therapeutics price target lowered to $1 from $3 at Chardan
2M ago
OTLK
Premium
The Fly
Outlook Therapeutics price target lowered to 50c from $1 at H.C. Wainwright
2M ago
OTLK
Premium
The Fly
Morning Movers: Baidu jumps following proposed spinoff of Kunlunxin
2M ago
W
LI
Premium
Company Announcements
FDA Issues New Setback for Outlook Therapeutics’ LYTENAVA
2M ago
8K
OTLK
Premium
Market News
Why is Outlook Therapeutics (OTLK) Stock Down 61% in Pre-Market Trading?
2M ago
OTLK
Premium
The Fly
FDA says cannot approve Outlook Therapeutics ONS-5010 BLA in present form
2M ago
OTLK
Premium
The Fly
Outlook Therapeutics Inc trading resumes
2M ago
OTLK
Premium
The Fly
Outlook Therapeutics Inc trading halted, news pending
2M ago
OTLK
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
BTQ
BILI
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/24/25
2M ago
EB
VTI
Premium
Ratings
Outlook Therapeutics: Strengthened Case for ONS-5010 Drives Attractive Risk/Reward and Increased $10 Price Target
2M ago
OTLK
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
